Covered recipient · General Payments record
SHERRIE L BOUISSEY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$2,810.96
- Reported across 171 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $355.60 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $183.86 | 8 |
| Novo Nordisk AS | $92.26 | 6 |
| PFIZER INC. | $23.61 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.31 | 1 |
| Lilly USA, LLC | $17.01 | 1 |
| Acerta Pharma LLC | $15.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.55 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106804605 | CMS |
| ABBVIE INC. | $25.34 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106804607 | CMS |
| ABBVIE INC. | $26.25 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106804609 | CMS |
| ABBVIE INC. | $21.11 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106804611 | CMS |
| ABBVIE INC. | $10.30 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106804613 | CMS |
| ABBVIE INC. | $21.11 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106804615 | CMS |
| ABBVIE INC. | $24.30 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106804617 | CMS |
| ABBVIE INC. | $34.90 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106804619 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.55 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105509766 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.31 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117953455 | CMS |
| Lilly USA, LLC | $17.01 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135954115 | CMS |
| Novo Nordisk Inc | $18.59 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100652813 | CMS |
| Novo Nordisk Inc | $17.44 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100468686 | CMS |
| Novo Nordisk Inc | $14.75 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100493437 | CMS |
| Novo Nordisk Inc | $13.38 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100481081 | CMS |
| Novo Nordisk Inc | $14.78 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100656697 | CMS |
| Novo Nordisk Inc | $13.32 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100496663 | CMS |
| PFIZER INC. | $23.61 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131093843 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.